Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.195
+0.065 (5.75%)
At close: Jun 26, 2026, 4:00 PM EDT
1.180
-0.015 (-1.26%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Tiziana Life Sciences Employees
Tiziana Life Sciences had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,843,100
Market Cap
152.58M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Molecular Partners AG | 134 |
| Caribou Biosciences | 97 |
| Alpha Cognition | 71 |
| Tenaya Therapeutics | 70 |
| Acumen Pharmaceuticals | 61 |
| Pyxis Oncology | 56 |
| Corbus Pharmaceuticals Holdings | 36 |
TLSA News
- 3 days ago - Tiziana Life Sciences doses last patient in intranasal foralumab trial - TheFly
- 3 days ago - Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial - GlobeNewsWire
- 13 days ago - Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares - TheFly
- 13 days ago - Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 5 weeks ago - Tiziana fully enrolls Phase 2 placebo-controlled MS trial - TheFly
- 5 weeks ago - Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial - GlobeNewsWire
- 5 weeks ago - Tiziana Life Sciences announces updated intranasal foralumab data - TheFly